Friday, June 30, 2023 2:37:22 PM
https://www.ctri.nic.in/Clinicaltrials/pdf_generate.php?trialid=67454&EncHid=&modid=&compid=%27,%2767454det%27
https://clinregs.niaid.nih.gov/country/india#
I'm not sure what this does to your hypothesis that you repeated over and over again here, something about "in all the history of ...., if someone hasn't gotten an IND in ... x ... years, they never have gotten one and never will," but I'd say it destroys it pretty well, in spite of the inane repetition of it. I guess someone had to be first biotech to be the longest one in preclinical development and a breaker of your "rule" / observation! I guess you were wrong with your prediction, despite dozens of repetitions of it over 7+ years. Being right for 7 years was pretty good, though!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=121988456
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170460706
Will see if they if they have any hint of decent results, if they will be able to attract a partner or raise funds to go it alone, and if they will be coming to the US and will get an IND here too.
P.S. Another company that raised over $100M and still in product development over ~2 decades plus is the private company, Brilliant Light Power. Will see if they start getting some traction this year too. They also have lots of doubters and detractors.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • May 16, 2024 8:13 AM
FEATURED Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • May 15, 2024 10:30 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM
Swifty Global Announces Impressive Financial Results for Q1 2024 • DRCR • May 15, 2024 10:25 AM
Branded Legacy Inc. Invites Shareholders to Celebrate Milestones at Open House: Announces Share Buyback and Commitment to Authorized Share Count • BLEG • May 15, 2024 8:30 AM